Eli Lilly to sell new Zepbound option for about half price of injection pens

Patients would draw their own doses of the weight-loss drug from glass vials that are easier to produce.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Amid the hype and promise, a growing tension is becoming clear: the reality of what AI can deliver versus what it can't. ...